Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Brain Research|January 26, 2020
Alpha<sub>2</sub>-adrenergic receptor agonists prevent emotional hyperthermiaAnna Antipov, Mariana Brizuela, William W Blessing, et al.Scientific Reports|December 22, 2019
Activating dopamine D2 receptors reduces brown adipose tissue thermogenesis induced by psychological stress and by activation of the lateral habenulaMariana Brizuela, Anna Antipov, William W Blessing, et al.Vaccines|May 25, 2024
Advax-SM™-Adjuvanted COBRA (H1/H3) Hemagglutinin Influenza VaccinesPedro L Sanchez, Greiciely Andre, Anna Antipov, et al.Immunology|May 18, 2023
Ability of SpikoGen®, an Advax-CpG adjuvanted recombinant spike protein vaccine, to induce cross-neutralising antibodies against SARS-CoV-2 variantsYoshikazu Honda-Okubo, Anna Antipov, Greiciely Andre, et al.Burns : Journal of the International Society for Burn Injuries|June 24, 2025
Risk factors for antimicrobial resistance in paediatric burn infections: Insights from a retrospective cohort studyAnteneh Amsalu, Anton Alvaro, Steven Huang, et al.Scientific Reports|June 5, 2026
Next-generation antimicrobial dermal matrix eradicates polymicrobial biofilms and modulates inflammation in in vitro and ex vivo wound modelsVan Vo, Hanif Haidari, Anteneh Amsalu, et al.Vaccine|February 6, 2025
Immunogenicity and safety study of a single dose of SpikoGen® vaccine as a heterologous or homologous intramuscular booster following a primary course of mRNA, adenoviral vector or recombinant protein COVID-19 vaccine in ambulatory adultsYoshikazu Honda-Okubo, Dimitar Sajkov, Bruce Wauchope, et al.Journal of Veterinary Pharmacology and Therapeutics|February 12, 2024
Safety and immunogenicity of an adjuvanted recombinant spike protein-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, SpikeVet™, in selected Carnivora, Primates and Artiodactyla in Australian zoosDavid J McLelland, Michael Lynch, Larry Vogelnest, et al.Pageof 1